Jaguar Health (JAGX) Non-Current Assets (2014 - 2026)

Jaguar Health's (JAGX) quarterly Non-Current Assets came in at $17.2 million in Q1 2026, down 18.06% year-on-year from $21.0 million in Q1 2025, and up 205.38% on a QoQ basis from -$16.3 million in Q4 2025.

Jaguar Health (JAGX) Non-Current Assets (2014 - 2026) Analysis & Trends

Jaguar Health (JAGX) has 13 years of Non-Current Assets data on file, last reported at $17.2 million in Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 18.06% year-over-year to $17.2 million in Q1 2026; TTM through Mar 2026 was $41.3 million, a 51.63% decrease from a year earlier, with the FY2025 full-year figure at -$16.3 million, down 177.0% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $17.2 million, up from -$16.3 million in the prior quarter.
  • Over the last five years, Non-Current Assets for JAGX reached as high as $26.5 million in Q2 2022 and fell as low as -$16.3 million in Q4 2025.
  • Historically, Non-Current Assets has averaged $20.3 million across 5 years, with a median of $21.8 million in 2024.
  • Across the five-year window, Non-Current Assets advanced 5.06% in 2022 and sank 177.0% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at $25.1 million in 2022, then retreated by 9.28% to $22.8 million in 2023, then fell by 6.9% to $21.2 million in 2024, then sank by 177.0% to -$16.3 million in 2025, then jumped by 205.38% to $17.2 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $17.2 million in Q1 2026, -$16.3 million in Q4 2025, and $20.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Nanobiotix 1,782.24 Bn 1,782.18 Bn - 5.70 Mn
2 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - 30.30 Mn
3 BeOne Medicines 473.46 Bn 468.66 Bn 1.35 Bn 1.95 Bn
4 Vertex Pharmaceuticals 123.84 Bn 116.59 Bn 2.59 Bn 14.75 Bn
5 Regeneron Pharmaceuticals 71.69 Bn 62.94 Bn 3.31 Bn 22.66 Bn
6 Belite Bio 62.15 Bn 62.15 Bn - 289.41 Mn
7 Argenx Se 54.74 Bn 49.55 Bn 1.41 Bn 1.96 Bn
8 Alnylam Pharmaceuticals 38.08 Bn 35.07 Bn 959.66 Mn 910.24 Mn
9 Revolution Medicines 36.07 Bn 36.07 Bn - 285.82 Mn
10 Jaguar Health 520,945.88 -9.54 Mn 19.11 Mn 17.22 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 17.22 Mn
Dec 31, 2025 -16.35 Mn
Sep 30, 2025 20.07 Mn
Jun 30, 2025 20.37 Mn
Mar 31, 2025 21.02 Mn
Dec 31, 2024 21.23 Mn
Sep 30, 2024 21.82 Mn
Jun 30, 2024 21.35 Mn
Mar 31, 2024 21.68 Mn
Dec 31, 2023 22.80 Mn
Sep 30, 2023 23.32 Mn
Jun 30, 2023 23.95 Mn
Mar 31, 2023 24.57 Mn
Dec 31, 2022 25.13 Mn
Sep 30, 2022 26.08 Mn
Jun 30, 2022 26.52 Mn
Mar 31, 2022 24.43 Mn
Dec 31, 2021 24.83 Mn
Sep 30, 2021 35.25 Mn
Jun 30, 2021 25.25 Mn